Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 42, 2010 - Issue 11-12
Submit an article Journal homepage
259
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment

Giuseppe Valenza Institute of Hygiene and MicrobiologyCorrespondence[email protected]
,
Kerstin Radike Department of Paediatrics, University of Würzburg, Würzburg, Germany
,
Christoph Schoen Institute of Hygiene and Microbiology
,
Stephan Horn Department of Paediatrics, University of Würzburg, Würzburg, Germany
,
Anett Oesterlein Institute of Hygiene and Microbiology
,
Matthias Frosch Institute of Hygiene and Microbiology
,
Marianne Abele-Horn Institute of Hygiene and Microbiology
&
Helge Hebestreit Department of Paediatrics, University of Würzburg, Würzburg, Germany
 show all
Pages 885-889 | Received 08 Jun 2010, Accepted 08 Jul 2010, Published online: 25 Aug 2010

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Foroud Shahbazi & Simin Dashti-Khavidaki. (2015) Colistin: efficacy and safety in different populations. Expert Review of Clinical Pharmacology 8:4, pages 423-448.
Read now
Cordula Koerner-Rettberg & Manfred Ballmann. (2014) Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. Core Evidence 9, pages 99-112.
Read now
Michael D Parkins & J Stuart Elborn. (2011) Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis. Expert Review of Respiratory Medicine 5:5, pages 609-622.
Read now

Articles from other publishers (8)

Danni Li & Elena K. Schneider-Futschik. (2023) Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis. Antibiotics 12:3, pages 484.
Crossref
Parisa Bonyadi, Narjes Tehrani Saleh, Mohadeseh Dehghani, Mahsa Yamini & Kumarss Amini. (2022) Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis. Microbial Pathogenesis 165, pages 105461.
Crossref
Jaime Lora-Tamayo, Oscar Murillo & Javier Ariza. 2019. Polymyxin Antibiotics: From Laboratory Bench to Bedside. Polymyxin Antibiotics: From Laboratory Bench to Bedside 181 195 .
S. Stefani, S. Campana, L. Cariani, V. Carnovale, C. Colombo, M.M. Lleo, V.D. Iula, L. Minicucci, P. Morelli, G. Pizzamiglio & G. Taccetti. (2017) Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. International Journal of Medical Microbiology 307:6, pages 353-362.
Crossref
Muhammad-Hariri Mustafa, Hussein Chalhoub, Olivier Denis, Ariane Deplano, Anne Vergison, Hector Rodriguez-Villalobos, Michael M. Tunney, J. Stuart Elborn, Barbara C. Kahl, Hamidou Traore, Francis Vanderbist, Paul M. Tulkens & Françoise Van Bambeke. (2016) Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial Agents and Chemotherapy 60:11, pages 6735-6741.
Crossref
M. C. Gaspar, W. Couet, J.-C. Olivier, A. A. C. C. Pais & J. J. S. Sousa. (2013) Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. European Journal of Clinical Microbiology & Infectious Diseases 32:10, pages 1231-1252.
Crossref
Gerard McCaughey, Paul Diamond, J. Stuart Elborn, Matt McKevitt & Michael M. Tunney. (2013) Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions. PLoS ONE 8:7, pages e69763.
Crossref
Amélie Rognon, Christophe Curti, Marc Montana, Thierry Terme, Pascal Rathelot & Patrice Vanelle. (2011) Efficacité et avenir de l’aérosolthérapie dans le traitement des infections à Pseudomonas aeruginosa chez les patients atteints de mucoviscidose. Therapies 66:6, pages 481-491.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.